Omega-3 Polyunsaturated Fatty Acid (PUFA) Status in Major Depressive Disorder With Comorbid Anxiety Disorders
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although lower levels of omega-3 polyunsaturated fatty acids (PUFAs) are found in major depressive disorder, less is known about PUFA status and anxiety disorders. METHOD: Medication-free participants with DSM-IV-defined major depressive disorder (MDD), with (n = 18) and without (n = 41) comorbid DSM-IV anxiety disorders, and healthy volunteers (n = 62) were recruited from October 2006 to May 2010 for mood disorder studies at the New York State Psychiatric Institute. Participants were 18-73 years of age (mean age, 35.8 ± 12.6 years). Depression and anxiety severity was assessed using depression and anxiety subscales from the 17-item Hamilton Depression Rating Scale. Plasma PUFAs eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) and the ratio of arachidonic acid (AA; 22:4n-6) to EPA (AA:EPA) were quantified. This secondary analysis employed analysis of variance with a priori planned contrasts to test for diagnostic group differences in log-transformed PUFA levels (logDHA, logEPA, and logAA:EPA). RESULTS: Plasma levels of logDHA (F(2,118) = 4.923, P = .009), logEPA (F(2,118) = 6.442, P = .002), and logAA:EPA (F(2,118) = 3.806, P = .025) differed across groups. Participants with MDD had lower logDHA (t(118) = 2.324, P = .022) and logEPA (t(118) = 3.175, P = .002) levels and higher logAA:EPA levels (t(118) = -2.099, P = .038) compared with healthy volunteers. Lower logDHA (t(118) = 2.692, P = .008) and logEPA (t(118) = 2.524, P = .013) levels and higher logAA:EPA levels (t(118) = -2.322, P = .022) distinguished anxious from nonanxious MDD. Depression severity was not associated with PUFA plasma levels; however, anxiety severity across the entire sample correlated negatively with logDHA (r(p) = -0.22, P = .015) and logEPA (r(p) = -0.25, P = .005) levels and positively with logAA:EPA levels (r(p) = 0.18, P = .043). CONCLUSIONS: The presence and severity of comorbid anxiety were associated with the lowest EPA and DHA levels. Further studies are needed to elucidate whether omega-3 PUFA supplementation may preferentially alleviate MDD with more severe anxiety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“their levels are reduced in patients with anxiety and depression [162,163]”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,094
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525
(1999) · PubMed · Cited by 2,062
Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
Simopoulos, A. P. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719248 · Cited by 2,009
Cited by
The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J., & Wlaź, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105840 · Cited by 857
Impact of Omega-3 Fatty Acids on the Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122645 · Cited by 741
“Zonulin, a detectable protein in human serum [63], has been shown to reflect intestinal permeability [64,65].”
BackgroundThe Prevalence of Depression, Anxiety and Stress and Their Associated Factors in College Students.
Ramón-Arbués, E., Gea-Caballero, V., Granada-López, J. M., Juárez-Vela, R., Pellicer-García, B., & Antón-Solanas, I. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197001 · Cited by 637
Brain membrane lipids in major depression and anxiety disorders
Müller, C. P., Reichel, M., Mühle, C., Rhein, C., Gulbins, E., & Kornhuber, J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.014 · Cited by 308
“Biochimica et Biophysica Acta 1851 (2015) 1052–1065 Contents lists available at ScienceDirect Biochimica et Biophysica Acta j ourna l homepage: www.e lsev ie r .com/ locate /bba l ip brought to you by COREView metadata, citation and similar papers at core.ac.uk provided by Elsevier - Publisher Connector Review Brain m…”
BackgroundInfluentialLiu, J. J., Green, P., John Mann, J., Rapoport, S. I., & Sublette, M. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.11.059 · Cited by 235
Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data
Bozzatello, P., Brignolo, E., De Grandi, E., & Bellino, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5080067 · Cited by 179
Omega-3 fatty acids and mental health
Lange, K. W. (2020) · Global Health Journal · doi:10.1016/j.glohj.2020.01.004 · Cited by 171
Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
Larrieu, T., & Layé, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01047 · Cited by 162
Su, K.-P., Tseng, P.-T., Lin, P.-Y., Okubo, R., Chen, T.-Y., Chen, Y.-W., & Matsuoka, Y. J. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.2327 · Cited by 153
Davis, D. J., Hecht, P. M., Jasarevic, E., Beversdorf, D. Q., Will, M. J., Fritsche, K., & Gillespie, C. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.09.003 · Cited by 112
Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders
Thesing, C. S., Bot, M., Milaneschi, Y., Giltay, E. J., & Penninx, B. W. J. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.10.005 · Cited by 123
“A recent study showed that participants with depression and comorbid anxiety had even lower N-3 PUFAs levels than depressed patients without comorbid anxiety(Liu et al., 2013).”
Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders
Wu, A., Noble, E. E., Tyagi, E., Ying, Z., Zhuang, Y., & Gómez‐Pinilla, F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.005 · Cited by 97
“Docosahexaenoic acid (DHA, C22: 6n-30) is the most prevalent omega 3 (n-3) fatty acid in brain tissue, and its deficiency is linked to several neurocognitive disorders such as anxietylike behavior [1, 2], Alzheimer’s disease [3], major depressive disorder [4], schizophrenia [5] with psychosis [6] and impaired attentio…”
Martins, B., Bandarra, N. M., & Figueiredo‐Braga, M. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1573800 · Cited by 100
McNamara, R. K., Strimpfel, J., Jandacek, R., Rider, T., Tso, P., Welge, J. A., Strawn, J. R., & DelBello, M. P. (2014) · PharmaNutrition · doi:10.1016/j.phanu.2014.02.002 · Cited by 81
“Consistent with some previous studies [26,59,60], but not others [61-63], DHA, EPA+DHA and the AA/EPA ratio were not significantly correlated with baseline CDRS-R total scores.”
ResultTrebatická, J., Hradečná, Z., Surovcová, A., Katrenčíková, B., Gushina, I., Waczulíková, I., Sušienková, K., Garaiová, I., Šuba, J., & Ďuračková, Z. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112911 · Cited by 86
Ramsden, C. E., Faurot, K. R., Zamora, D., Palsson, O. S., MacIntosh, B., Gaylord, S. A., Taha, A. Y., Rapoport, S. I., Hibbeln, J. R., Davis, J. M., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460348.84965.47 · Cited by 72
“n-3 and n-6 fatty acids are also proposed to modulate the risk of developing depression and anxiety.(1,4,15,16,18,24,44,50) Therefore, in addition to physical pain relief, targeted manipulation of dietary n-3 and n-6 fatty acids may be able to reduce psychological distress and enhance HRQOL.”
BackgroundNutrition as Metabolic Treatment for Anxiety
Norwitz, N. G., & Naidoo, U. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.598119 · Cited by 74
“Similar observations have been made by others (76), and these associations are backed by interventional trials.”
[Metabolic difference between visceral fat and subcutaneous abdominal fat].
Björntorp, P. A. (2000) · PubMed · Cited by 83
Messamore, E., & McNamara, R. K. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0196-5 · Cited by 72
“Robust erythrocyte EPA +DHA deficits were also observed in non-depressed patients with social anxiety disorder [135], and plasma EPA +DHA deficits were observed in MDD patients with comorbid anxiety disorders [136].”
BackgroundMcNamara, R. K. (2016) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2016.04.004 · Cited by 58
“Some studies (Clayton et al., 2008; Adams et al., 1996; Edwards et al., 1998), but not others (Assies et al., 2010; Liu et al., 2013; McNamara et al., 2010a), have observed an inverse correlation between blood EPA+DHA levels, or a positive correlation between the AA/EPA ratio, and depression…”
BackgroundChataigner, M., Mortessagne, P., Lucas, C., Pallet, V., Layé, S., Mehaignerie, A., Bouvret, E., Dinel, A., & Joffre, C. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.022 · Cited by 56
Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders
Sethi, S., Hayashi, M. A., Sussulini, A., Tasic, L., & Brietzke, E. (2017) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117656 · Cited by 44
Puurunen, J., Tiira, K., Lehtonen, M., Hanhineva, K., & Lohi, H. (2016) · Behavioral and Brain Functions · doi:10.1186/s12993-016-0091-2 · Cited by 51
“Together with fatty acids they have been associated with anxiety-related diseases and behavior in humans and mice [17, 35–41].”
BackgroundNock, T. G., Chouinard‐Watkins, R., & Plourde, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.004 · Cited by 39
Trim the fat: the role of omega-3 fatty acids in psychopharmacology
Nasir, M., & Bloch, M. H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319869791 · Cited by 39
Morgese, M. G., & Trabace, L. (2016) · Brain Sciences · doi:10.3390/brainsci6030024 · Cited by 46
“In this regard, low PUFA dietary intake has been linked to anxiety disorders [218], while n-3 PUFA supplementation showed anxiolytic effects [219].”
BackgroundSalehi‐Abargouei, A., Esmaillzadeh, A., Azadbakht, L., Keshteli, A. H., Afshar, H., Feizi, A., Feinle‐Bisset, C., & Adibi, P. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.02.002 · Cited by 38
Vega-Torres, J. D., Haddad, E., Lee, J. B., Kalyan-Masih, P., Maldonado, W. I., Pérez, L. L., Vázquez, D. M. P., Torres, Y. A., Santiago, J. M., Obenaus, A., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.01.011 · Cited by 37
Beier, A. M., Lauritzen, L., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.06.012 · Cited by 31
“Portions of this dataset have been included in other analyses with different objectives (Liu et al., 2013; Sublette et al., 2011c; Sublette et al., 2011d).”
MethodSantos, P. C. D., Herrmann, A. P., Elisabetsky, E., & Piato, Â. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2018-0005 · Cited by 37
Trebatická, J., Hradečná, Z., Böhmer, F., Vaváková, M., Waczulíková, I., Garaiová, I., Luha, J., Škodáček, I., Šuba, J., & Ďuračková, Z. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0167-2 · Cited by 30
Natacci, L. C., Marchioni, D. M. L., Goulart, A. C., Nunes, M. A., Moreno, A. B., Cardoso, L. O., Giatti, L., Molina, M. D. C. B., Santos, I. S., Brunoni, A. R., et al. (2018) · Nutrients · doi:10.3390/nu10060663 · Cited by 33
“[36] identified in adults with major depressive disorder (MDD), with and without comorbid DSM-IV anxiety disorders and healthy controls, that the presence and severity of comorbid anxiety were negatively associated with EPA and DHA levels.”
BackgroundHigher dietary fat quality is associated with lower anxiety score in women: a cross-sectional study
Fatemi, S. F., Siassi, F., Qorbani, M., & Sotoudeh, G. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00264-9 · Cited by 29
The Role of Dietary Supplements in Depression and Anxiety – A Narrative Review
Hoffmann, K., Emons, B., Brunnhuber, S., Karaca, S., & Juckel, G. (2019) · Pharmacopsychiatry · doi:10.1055/a-0942-1875 · Cited by 27
“Low levels of PUFA were associated with higher levels of both depression and anxiety [32, 33].”
BackgroundShibata, M., Ohara, T., Yoshida, D., Hata, J., Mukai, N., Kawano, H., Kanba, S., Kitazono, T., & Ninomiya, T. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.004 · Cited by 24
Ribichini, E., Scalese, G., Mocci, C., & Severi, C. (2024) · Nutrients · doi:10.3390/nu16203515 · Cited by 26
“Research has shown that levels of these PUFAs are reduced in individuals suffering from anxiety and depression [24,25].”
BackgroundAssociations between major dietary patterns and anxiety in middle-aged adults in eastern China
Xu, F., Chong, B.-Q., Cai, T., Zhang, J., & Lv, J. (2020) · Public Health Nutrition · doi:10.1017/s1368980020000221 · Cited by 20
Effects of n-3 PUFA enriched and n-3 PUFA deficient diets in naïve and Aβ-treated female rats
Bové, M., Mhillaj, E., Tucci, P., Giardino, I., Schiavone, S., Morgese, M. G., & Trabace, L. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.017 · Cited by 20
Omega-3 fatty acids improve behavioral coping to stress in multiparous rats
Gonzales, E., Barrett, D. W., Shumake, J., Gonzalez-Lima, F., & Lane, M. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.010 · Cited by 18
Yang, R., Wang, L., Jin, K., Cao, S., Wu, C., Guo, J., Chen, J., Tang, H., & Tang, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.876152 · Cited by 26
“The potential anxiolytic benefits have been discovered over the past decade (53), and several possible explanations have been proposed.”
BackgroundOmega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus
Salek, M., Hooshiar, S. H., Salek, M., Poorebrahimi, M., & Jafarnejad, S. (2022) · Lupus · doi:10.1177/09612033221140724 · Cited by 20
“Anxiety disorders often appear simultaneously with major depression, this increases the possibility that omega-3 levels associate with their pathophysiology and the effectiveness of supplementation as a treatment for anxiety and depression disorders.(89) A few studies consider the effect of omega-3 on fatigue symptoms…”
BackgroundOshima, Y., Watanabe, T., Endo, S., Hata, S., Watanabe, T., Osada, K., & Takenaka, A. (2017) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2017.1403888 · Cited by 20
“It has been shown that intracellular n-3 PUFA levels in patients experiencing anxiety and depression are low and that anxiety can be alleviated by the addition of n-3 type PUFA [8,9].”
BackgroundChukaew, P., Leow, A., Saengsawang, W., & Rasenick, M. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0724-6 · Cited by 23
Savard, J., Moussa, H., Pelletier, J., Julien, P., Lacombe, L., Tiguert, R., Caumartin, Y., Dujardin, T., Toren, P., Pouliot, F., et al. (2023) · Cancer Medicine · doi:10.1002/cam4.6598 · Cited by 17
Bipolar disorder moderates associations between linoleic acid and markers of inflammation
Chang, Y.-W., Assari, S., Prossin, A. R., Stertz, L., McInnis, M. G., & Evans, S. J. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.10.021 · Cited by 15
“PUFA may also play a key role in mood (Liu et al., 2013).”
BackgroundShams‐Rad, S., Bidaki, R., Nadjarzadeh, A., Salehi‐Abargouei, A., de Courten, B. V., & Mirzaei, M. (2022) · BMC Public Health · doi:10.1186/s12889-022-13518-w · Cited by 15
Sornborger, J., Fann, A. V., Serpa, J. G., Ventrelle, J., n, M. S.-R., Foynes, M. M., Carleton, M. E., Sherrill, A. M., Kao, L., Jakubovic, R. J., et al. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20170026 · Cited by 19
Association between plasma polyunsaturated fatty acids and depressive among US adults
Wang, M., Yan, X., Li, Y., Li, Q., Xu, Y., Huang, J., Gan, J., & Yang, W. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1342304 · Cited by 16
“There were also some studies that did not observe an association between plasma PUFAs levels and depression (31, 33, 49, 72, 73).”
ResultDietary omega-3 polyunsaturated fatty acid supplementation in an animal model of anxiety
Ross, B. M., Malik, I., & Babay, S. (2016) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2016.09.004 · Cited by 14
Haghighatdoost, F., Feizi, A., Esmaillzadeh, A., Keshteli, A. H., Roohafza, H., Afshar, H., & Adibi, P. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1485611 · Cited by 13
Carvajal, F., Sánchez-Gil, A., Cardona, D., Rincón‐Cervera, M. Á., & Lerma-Cabrera, J. M. (2023) · Nutrients · doi:10.3390/nu15132993 · Cited by 11
“Recent research has shown that the presence and severity of comorbid depressive and anxiety disorder were associated with lower n-3 PUFA levels [100,111].”
BackgroundAbnormal erythrocyte fatty acid composition in first-diagnosed, drug-naïve patients with depression
Wang, L., Liu, T., Guo, J., Zhao, T., Tang, H., Jin, K., Li, L., Xue, Y. W., Yang, R., Chen, J., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.023 · Cited by 11
Cerebral Venous-Associated Brain Damage May Lead to Anxiety and Depression
Lan, D., Song, S., Jia, M., Wang, M., Jiao, B., Liu, Y., Ding, Y., Ji, X., & Meng, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236927 · Cited by 9
“Previous studies showed that patients with comorbidities of anxiety and depression had abnormal EEG signals in the frontal, parietal, and insular cortices [51].”
BackgroundLipids in the Treatment of Mental Disorders
Lange, K. W. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio120 · Cited by 7
van der Merwe, S., Manley, M., & Wicht, M. M. (2018) · Journal of Near Infrared Spectroscopy · doi:10.1177/0967033518795811 · Cited by 7
Yang, H.-T., Wang, R.-Y., Huang, S., Huang, C., & Su, K. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.01.006 · Cited by 5
“The deficits of n-3 and n-6 PUFA are related to stress and depressive disorder, chronic supplementation of n3 PUFA might have improving effects [36,37].”
BackgroundGallini, A., Yrondi, A., Cantet, C., Poncet, M., Vellas, B. J., Schmitt, L., & Andrieu, S. (2019) · The journal of nutrition health & aging · doi:10.1007/s12603-019-1252-4 · Cited by 5
Fleig, K., Haslinger, L., Dawczynski, C., & Kolassa, I. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1748196 · Cited by 6
“In contrast, a balanced long-chain omega-3 PUFA status may act as a resilience factor, potentially mitigating anxiety symptoms in individuals exposed to stress (89).”
Vayghan, H. J., Mirmajidi, S., Mollarasouli, Z., Vahid, F., Saleh‐Ghadimi, S., & Dehghan, P. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200176 · Cited by 5
Luke, A. K., Evans, E. W., Bond, D. S., & Thomas, J. G. (2016) · Obesity Science & Practice · doi:10.1002/osp4.21 · Cited by 4
Alharbi, M. H. (2023) · Psychology Research and Behavior Management · doi:10.2147/prbm.s418005 · Cited by 4
“Marital Status Married 51(46) 55(40) 20(38) 4.”
BackgroundInfluentialSherafatmanesh, S., Madadizadeh, F., Hosseinzadeh, M., Mohammadi, M., Mirzaei, M., Khosravi‐Boroujeni, H., & Salehi‐Abargouei, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3483452/v1 · Cited by 2
Park, S., Lee, C.-H., & Lee, H. (2018) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2018.6.28.3.239 · Cited by 1
A NON-TARGETED METABOLOMICS APPROACH TO CANINE ANXIETY
Puurunen, J. (2015) · UEF eRepo (University of Eastern Finland)
A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks
Hutchens, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-42307-4_11
Natacci, L. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-23102018-101131 · Cited by 1
Diet, Inflammation, Gut Microbiome, and Mental Health
Polokowski, A. R. (2019) · CUNY Academic Works (City University of New York) · Cited by 1
Shams‐Rad, S., Bidaki, R., Nadjarzadeh, A., Salehi-Abargouei, A., de Courten, B., & Mirzaei, M. (2022) · Figshare · doi:10.6084/m9.figshare.20004711
Zou, H., Jiang, C., Qi, X., Miranda, O., Xie, T., Courcoulas, A. P., & Wang, L. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101061
“This may be attributed to its neuroprotective role, as it can modulate neuroinflammation and regulate the hypothalamic-pituitary-adrenal (HPA) axis, which is implicated in the pathophysiology of anxiety (Larrieu and Layé, 2018; Liu et al., 2013; Larrieu et al., 2014).”
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Sherafatmanesh, S., Madadizadeh, F., Hosseinzadeh, M., Mohammadi, M. R., Mirzaei, M., Khosravi‐Boroujeni, H., & Salehi‐Abargouei, A. (2026) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_130_24 · Cited by 2
“[7,10] For instance, anxiety and depression have been linked to the dietary consumption of omega‑3 fatty acids, [11] vitamin B6, [12] iron, [13] fish, [14] and vegetables.”
Selvalatchmanan, J., Ji, S., Chen, L., Chen, H., Chong, M. F., Eriksson, J. G., CHONG, Y.-S., Chua, M. C., Tan, K. H., Bradley, D., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1908654
“Similarly, low plasma PUFA levels have been associated with anxiety and depressive disorders, with n-3 PUFAs inversely associated with mental health symptoms (55–57).”
Prevalence of mental health disorders among university students in northern Morocco
Bousgheïri, F., Sammoud, K., Lemrabett, S., Echater, S., Benhaddouch, Y., Belaatar, M., Senhaji, M., Ammouri, A. E., & Najdi, A. (2026) · Discover Public Health · doi:10.1186/s12982-026-02949-0
Metadata
- Authors
- Liu, J. J., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E.
- Affiliations
- Columbia University (US)
- New York State Psychiatric Institute (US)
- Nathan Kline Institute for Psychiatric Research (US)
- Corresponding author
- Sublette, M. Elizabeth
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2013-07-15
- Volume
- 74
- Issue
- 07
- Pages
- 732-738
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC3905735
- OpenAlex
- W2017367404
- Cited by
- 73
- References
- 93
- Citations by year
- 2026: 5 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 8 · 2019: 5 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 3 · 2014: 6
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- National Alliance for Research on Schizophrenia and Depression (MH076049)
- National Institutes of Health (5k08mh079033-02)
- National Institute of Mental Health (MH06218, K23MH076049, K-08 MH079033, R01MH048514, MH076049, MH079033, MH048514, P50MH062185)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, anxiety disorders, comorbidities, omega-3 polyunsaturated fatty acids, docosahexaenoic acid, eicosapentaenoic acid, arachidonic acid, plasma fatty acids, omega-3 deficiency, depression biomarkers, mood disorders, dietary fatty acid intake, omega-3 supplementation, omega-6 fatty acids
- MeSH terms
- Adult, Anxiety Disorders, Major Depressive Disorder, Female, Humans, Middle Aged, Psychiatric Status Rating Scales, Psychological Tests, Statistics as Topic, Fatty Acids, Omega-3, Comorbidity, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.